Healthcare Trust of America (HTA) 10-Q 3 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Jul. 27, 2016
Entity Information [Line Items]
Entity Registrant Name	HEALTHCARE TRUST OF AMERICA, INC.
Entity Central Index Key	1,360,604
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		137,942,553
Healthcare Trust of America Holdings, LP (HTALP)
Entity Information [Line Items]
Entity Registrant Name	Healthcare Trust of America Holdings, LP
Entity Central Index Key	1,495,491
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Real estate investments:
Land	$ 357,602	$ 303,706
Building and improvements	3,240,979	2,901,157
Lease intangibles	459,490	430,749
Real estate investments, gross	4,058,071	3,635,612
Accumulated depreciation and amortization	(741,186)	(676,144)
Real estate investments, net	3,316,885	2,959,468
Cash and cash equivalents	8,148	13,070
Restricted cash and escrow deposits	16,268	15,892
Receivables and other assets, net	145,851	141,703
Other intangibles, net	45,137	42,167
Total assets	3,532,289	3,172,300
Liabilities:
Debt	1,631,642	1,590,696
Accounts payable and accrued liabilities	90,123	94,933
Derivative financial instruments - interest rate swaps	5,393	2,370
Security deposits, prepaid rent and other liabilities	46,241	46,295
Intangible liabilities, net	37,226	26,611
Total liabilities	1,810,625	1,760,905
Commitments and contingencies
Redeemable noncontrolling interests	9,462	4,437
Equity/Partners' Capital:
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding	0	0
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 137,752,741 and 127,026,839 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	1,378	1,270
Additional paid-in capital	2,625,269	2,328,806
Cumulative dividends in excess of earnings	(1,006,888)	(950,652)
Total stockholders’ equity	1,619,759	1,379,424
Noncontrolling interests	92,443	27,534
Total equity	1,712,202	1,406,958
Total liabilities and equity/partners' capital	3,532,289	3,172,300
Healthcare Trust of America Holdings, LP (HTALP)
Real estate investments:
Land	357,602	303,706
Building and improvements	3,240,979	2,901,157
Lease intangibles	459,490	430,749
Real estate investments, gross	4,058,071	3,635,612
Accumulated depreciation and amortization	(741,186)	(676,144)
Real estate investments, net	3,316,885	2,959,468
Cash and cash equivalents	8,148	13,070
Restricted cash and escrow deposits	16,268	15,892
Receivables and other assets, net	145,851	141,703
Other intangibles, net	45,137	42,167
Total assets	3,532,289	3,172,300
Liabilities:
Debt	1,631,642	1,590,696
Accounts payable and accrued liabilities	90,123	94,933
Derivative financial instruments - interest rate swaps	5,393	2,370
Security deposits, prepaid rent and other liabilities	46,241	46,295
Intangible liabilities, net	37,226	26,611
Total liabilities	1,810,625	1,760,905
Commitments and contingencies
Redeemable noncontrolling interests	9,462	4,437
Equity/Partners' Capital:
Limited partners’ capital, 4,343,197 and 1,929,942 units issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	92,173	27,264
General partners’ capital, 137,752,741 and 127,026,839 units issued and outstanding as of June 30, 2016 and December 31, 2015, respectively	1,620,029	1,379,694
Total partners’ capital	1,712,202	1,406,958
Total liabilities and equity/partners' capital	$ 3,532,289	$ 3,172,300

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2016	Dec. 31, 2015
Equity:
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock
Equity:
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	137,752,741	127,026,839
Common stock, shares outstanding	137,752,741	127,026,839
Healthcare Trust of America Holdings, LP (HTALP)
Partners’ Capital:
Limited partner's capital, units issued	4,343,197	1,929,942
Limited partner's capital, units outstanding	4,343,197	1,929,942
General partner's capital, units issued	137,752,741	127,026,839
General partner's capital, units outstanding	137,752,741	127,026,839

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenues:
Rental income		$ 113,144	$ 99,243	$ 220,394	$ 197,695
Interest and other operating income		90	68	155	136
Total revenues		113,234	99,311	220,549	197,831
Expenses:
Rental		35,061	29,237	68,414	59,934
General and administrative		6,813	6,224	13,586	12,799
Acquisition-related		2,062	1,101	3,875	2,458
Depreciation and amortization		44,738	38,066	82,566	74,661
Impairment		0	1,655	0	1,655
Total expenses		88,674	76,283	168,441	151,507
Income before other income (expense)		24,560	23,028	52,108	46,324
Interest expense:
Interest related to derivative financial instruments		(659)	(820)	(1,304)	(1,375)
(Loss) gain on change in fair value of derivative financial instruments, net		(658)	1,314	(3,450)	(696)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		(1,317)	494	(4,754)	(2,071)
Interest related to debt		(13,989)	(14,159)	(28,117)	(27,963)
Gain on sale of real estate, net		4,212	0	4,212	0
(Loss) gain on extinguishment of debt, net		(22)	121	(22)	121
Other income		72	4	125	19
Net income		13,516	9,488	23,552	16,430
Net loss (income) attributable to noncontrolling interests	[1]	(442)	(196)	(618)	(334)
Net income attributable to common stockholders/unitholders		$ 13,074	$ 9,292	$ 22,934	$ 16,096
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.09	$ 0.07	$ 0.17	$ 0.13
Weighted average common shares/units outstanding:
Basic (in shares/units)		136,528	125,194	132,932	125,184
Diluted (in shares/units)		140,512	127,124	135,876	127,114
Dividends declared per common share (in usd per share)		$ 0.295	$ 0.290	$ 0.590	$ 0.580
Healthcare Trust of America Holdings, LP (HTALP)
Revenues:
Rental income		$ 113,144	$ 99,243	$ 220,394	$ 197,695
Interest and other operating income		90	68	155	136
Total revenues		113,234	99,311	220,549	197,831
Expenses:
Rental		35,061	29,237	68,414	59,934
General and administrative		6,813	6,224	13,586	12,799
Acquisition-related		2,062	1,101	3,875	2,458
Depreciation and amortization		44,738	38,066	82,566	74,661
Impairment		0	1,655	0	1,655
Total expenses		88,674	76,283	168,441	151,507
Income before other income (expense)		24,560	23,028	52,108	46,324
Interest expense:
Interest related to derivative financial instruments		(659)	(820)	(1,304)	(1,375)
(Loss) gain on change in fair value of derivative financial instruments, net		(658)	1,314	(3,450)	(696)
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments		(1,317)	494	(4,754)	(2,071)
Interest related to debt		(13,989)	(14,159)	(28,117)	(27,963)
Gain on sale of real estate, net		4,212	0	4,212	0
(Loss) gain on extinguishment of debt, net		(22)	121	(22)	121
Other income		72	4	125	19
Net income		13,516	9,488	23,552	16,430
Net loss (income) attributable to noncontrolling interests		4	(24)	(27)	(57)
Net income attributable to common stockholders/unitholders		$ 13,520	$ 9,464	$ 23,525	$ 16,373
Earnings per common share/unit - basic:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common share/unit - diluted:
Net income attributable to common stockholders/unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Weighted average common shares/units outstanding:
Basic (in shares/units)		140,512	127,203	135,877	127,266
Diluted (in shares/units)		140,512	127,203	135,877	127,266
Dividends declared per common share (in usd per share)		$ 0.295	$ 0.290	$ 0.590	$ 0.580
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Equity (Unaudited) - USD ($) $ in Thousands	Total	Class A Common Stock	Common StockClass A Common Stock	Additional Paid-In Capital	Cumulative Dividends in Excess of Earnings	Total Stockholders’ Equity	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2014			125,087,000
Beginning balance at Dec. 31, 2014	$ 1,476,421		$ 1,251	$ 2,281,932	$ (836,044)	$ 1,447,139	$ 29,282
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based award transactions, net (in shares)			155,000
Share-based award transactions, net	3,104		$ 1	3,103		3,104
Repurchase and cancellation of common stock (in shares)			(48,000)
Repurchase and cancellation of common stock	(1,298)			(1,298)		(1,298)
Dividends declared	(73,718)				(72,595)	(72,595)
Dividends declared							(1,123)
Net income	16,373				16,096	16,096	277
Ending balance (in shares) at Jun. 30, 2015			125,194,000
Ending balance at Jun. 30, 2015	1,420,882		$ 1,252	2,283,737	(892,543)	1,392,446	28,436
Beginning balance (in shares) at Dec. 31, 2015		127,026,839	127,027,000
Beginning balance at Dec. 31, 2015	1,406,958		$ 1,270	2,328,806	(950,652)	1,379,424	27,534
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net (in shares)			10,399,000
Issuance of common stock, net	291,685		$ 105	291,580		291,685
Issuance of operating partnership units in connection with an acquisition	70,754						70,754
Share-based award transactions, net (in shares)			203,000
Share-based award transactions, net	3,033		$ 2	3,031		3,033
Repurchase and cancellation of common stock (in shares)			(83,000)
Repurchase and cancellation of common stock	(2,287)		$ (1)	(2,286)		(2,287)
Redemption of noncontrolling interest and other (in shares)			207,000
Redemption of noncontrolling interest and other	(458)		$ 2	4,138		4,140	(4,598)
Dividends declared	(81,008)				(79,170)	(79,170)
Dividends declared							(1,838)
Net income	23,525				22,934	22,934	591
Ending balance (in shares) at Jun. 30, 2016		137,752,741	137,753,000
Ending balance at Jun. 30, 2016	$ 1,712,202		$ 1,378	$ 2,625,269	$ (1,006,888)	$ 1,619,759	$ 92,443

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Changes In Partners' Capital (Unaudited) - USD ($) $ in Thousands	Total	Healthcare Trust of America Holdings, LP (HTALP)	Healthcare Trust of America Holdings, LP (HTALP)General Partners’ Capital	Healthcare Trust of America Holdings, LP (HTALP)Limited Partners’ Capital
Balance as of beginning of period (in units) at Dec. 31, 2014			125,087,000	2,155,000
Balance as of beginning of period at Dec. 31, 2014		$ 1,476,421	$ 1,447,409	$ 29,012
Increase (Decrease) in Partners' Capital [Roll Forward]
Share-based award transactions, net (in units)			155,000	(225,000)
Share-based award transactions, net		3,104	$ 3,104
Redemption and cancellation of general partner units (in units)			(48,000)
Redemption and cancellation of general partner units		(1,298)	$ (1,298)
Distributions declared		(73,718)	(72,595)	$ (1,123)
Net income	$ 16,096	16,373	$ 16,096	$ 277
Balance as of end of period (in units) at Jun. 30, 2015			125,194,000	1,930,000
Balance as of end of period at Jun. 30, 2015		1,420,882	$ 1,392,716	$ 28,166
Balance as of beginning of period (in units) at Dec. 31, 2015			127,027,000	1,930,000
Balance as of beginning of period at Dec. 31, 2015		1,406,958	$ 1,379,694	$ 27,264
Increase (Decrease) in Partners' Capital [Roll Forward]
Issuance of general partner units (in units)			10,399,000
Issuance of general partner units, net		291,685	$ 291,685
Issuance of limited partner units in connection with an acquisition (in units)				2,620,000
Issuance of limited partner units in connection with an acquisition		70,754		$ 70,754
Share-based award transactions, net (in units)			203,000
Share-based award transactions, net		3,033	$ 3,033
Redemption and cancellation of general partner units (in units)			(83,000)
Redemption and cancellation of general partner units		(2,287)	$ (2,287)
Redemption of limited partner units and other (in units)			207,000	(207,000)
Redemption of limited partner units and other		(458)	$ 4,140	$ (4,598)
Distributions declared		(81,008)	(79,170)	(1,838)
Net income	$ 22,934	23,525	$ 22,934	$ 591
Balance as of end of period (in units) at Jun. 30, 2016			137,753,000	4,343,000
Balance as of end of period at Jun. 30, 2016		$ 1,712,202	$ 1,620,029	$ 92,173

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income	$ 23,552	$ 16,430
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	81,362	72,905
Share-based compensation expense	3,033	3,104
Bad debt expense	386	289
Gain on sale of real estate, net	(4,212)	0
Impairment	0	1,655
Loss (gain) on extinguishment of debt, net	22	(121)
Change in fair value of derivative financial instruments	3,450	696
Changes in operating assets and liabilities:
Receivables and other assets, net	(667)	(3,885)
Accounts payable and accrued liabilities	(5,983)	(12,024)
Prepaid rent and other liabilities	(4,543)	8,117
Net cash provided by operating activities	96,400	87,166
Cash flows from investing activities:
Investments in real estate	(336,760)	(224,345)
Proceeds from the sale of real estate	23,368	0
Capital expenditures	(21,826)	(13,131)
Restricted cash, escrow deposits and other assets	(426)	4,550
Net cash used in investing activities	(335,644)	(232,926)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	336,000	361,000
Payments on unsecured revolving credit facility	(293,000)	(167,000)
Borrowings on unsecured term loans	0	100,000
Payments on secured real estate term loan and mortgage loans	(22,791)	(67,171)
Deferred financing costs	0	(276)
Security deposits	765	183
Proceeds from issuance of common stock	292,984	0
Repurchase and cancellation of common stock	(2,287)	(1,298)
Dividends paid	(76,018)	(72,584)
Distributions paid to noncontrolling interest of limited partners	(1,331)	(930)
Net cash provided by financing activities	234,322	151,924
Net change in cash and cash equivalents	(4,922)	6,164
Cash and cash equivalents - beginning of period	13,070	10,413
Cash and cash equivalents - end of period	8,148	16,577
Healthcare Trust of America Holdings, LP (HTALP)
Cash flows from operating activities:
Net income	23,552	16,430
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other	81,362	72,905
Share-based compensation expense	3,033	3,104
Bad debt expense	386	289
Gain on sale of real estate, net	(4,212)	0
Impairment	0	1,655
Loss (gain) on extinguishment of debt, net	22	(121)
Change in fair value of derivative financial instruments	3,450	696
Changes in operating assets and liabilities:
Receivables and other assets, net	(667)	(3,885)
Accounts payable and accrued liabilities	(5,983)	(12,024)
Prepaid rent and other liabilities	(4,543)	8,117
Net cash provided by operating activities	96,400	87,166
Cash flows from investing activities:
Investments in real estate	(336,760)	(224,345)
Proceeds from the sale of real estate	23,368	0
Capital expenditures	(21,826)	(13,131)
Restricted cash, escrow deposits and other assets	(426)	4,550
Net cash used in investing activities	(335,644)	(232,926)
Cash flows from financing activities:
Borrowings on unsecured revolving credit facility	336,000	361,000
Payments on unsecured revolving credit facility	(293,000)	(167,000)
Borrowings on unsecured term loans	0	100,000
Payments on secured real estate term loan and mortgage loans	(22,791)	(67,171)
Deferred financing costs	0	(276)
Security deposits	765	183
Proceeds from issuance of general partner units	292,984	0
Repurchase and cancellation of general partner units	(2,287)	(1,298)
Distributions paid to general partner	(76,018)	(72,584)
Distributions paid to limited partners and redeemable noncontrolling interests	(1,331)	(930)
Net cash provided by financing activities	234,322	151,924
Net change in cash and cash equivalents	(4,922)	6,164
Cash and cash equivalents - beginning of period	13,070	10,413
Cash and cash equivalents - end of period	$ 8,148	$ 16,577

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business HTA, a Maryland corporation, and HTALP , a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006 . HTA operates as a REIT and is the general partner of HTALP , which is the operating partnership. As of June 30, 2016 , HTA owned a 96.9% partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP units) in HTALP . As the sole general partner of HTALP , HTA has the full, exclusive and complete responsibility for HTALP ’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which HTALP and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of HTALP . As a result, HTA does not conduct business itself, other than acting as the sole general partner of HTALP , issuing public equity from time to time and guaranteeing certain debts of HTALP . HTALP conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the United States (“U.S.”) based on gross leasable area (“GLA”). We invest in MOBs that will serve the future of healthcare delivery; primarily located on health system campuses, around university medical centers, or in core community outpatient locations. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our portfolio consists of MOBs and other facilities that serve the healthcare industry with an aggregate purchase price of $4.0 billion through June 30, 2016 . Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target accretive acquisitions of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT. Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2016
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The summary of significant accounting policies presented below is designed to assist in understanding our condensed consolidated financial statements. Such condensed consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to U.S. generally accepted accounting principles (“GAAP”) in all material respects and have been consistently applied in preparing our accompanying condensed consolidated financial statements. Basis of Presentation Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements. Interim Unaudited Financial Data Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the six months ended June 30, 2016 , except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. Principles of Consolidation As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include the accounts of HTA and its subsidiaries and consolidated joint venture arrangements. The portions of the operating partnership not owned by HTA are presented as non-controlling interests in HTA’s consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by HTA are presented as redeemable non-controlling interests in HTA’s consolidated balance sheets. In addition, as described in Note 1 - Organization and Description of Business , certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of June 30, 2016 and December 31, 2015 , there were approximately 4.3 million and 1.9 million , respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Our analysis of FASB ASU 2015-02 was concluded that the Company’s operating partnership and other joint venture arrangements are VIEs, as the limited partners in the related partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Accordingly, the Company consolidates its interest in the operating partnership and other joint venture arrangements. Although, as the Company holds what is deemed a majority voting interest in the operating partnership and other joint venture arrangements, it qualifies for the exemption from providing certain of the disclosure requirements associated with investments in VIEs. The Company will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above. Investments in Real Estate Depreciation expense of buildings and improvements for the three months ended June 30, 2016 and 2015 was $29.9 million and $24.7 million , respectively. Depreciation expense of buildings and improvements for the six months ended June 30, 2016 and 2015 was $55.6 million and $48.0 million , respectively. Recently Issued or Adopted Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no impact in the previous or current reporting periods’ consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Compensation Accounting. ASU 2016-09 includes multiple provisions intended to simplify various aspects of accounting for share-based compensation which includes, but is not limited to, the requirement that excess tax benefits be recorded within the income statement as opposed to additional paid-in-capital and treated as an operating activity within the statement of cash flows. In addition, ASU 2016-09 allows companies to make an accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-09 on our consolidated financial statements.

Investments in Real Estate

Investments in Real Estate	6 Months Ended
	Jun. 30, 2016
Investments [Abstract]
Investments in Real Estate	Investments in Real Estate For the six months ended June 30, 2016 , our investments had an aggregate purchase price of $435.8 million . We incurred $2.1 million of costs attributable to these investments, which were recorded in acquisition-related expenses in the accompanying condensed consolidated statements of operations. As part of the acquisitions, we assumed mortgage loans with an aggregate fair value of $19.9 million and issued 2,620,512 operating partnership units with a market value of $70.8 million . The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The purchase price allocation for each of our investments are preliminary and subject to change until allocations are finalized, which will be no later than 12 months from the date of acquisition. The preliminary allocations for these investments are set forth below in the aggregate for the six months ended June 30, 2016 and 2015 (in thousands): Six Months Ended June 30, 2016 2015 Land $ 53,806 $ 11,240 Building and improvements 347,729 200,071 Below market leasehold interests 1,404 2,350 Above market leases 3,582 3,279 In place leases 37,768 19,403 Below market leases (12,066 ) (5,912 ) Above market leasehold interests (50 ) (6,086 ) Below market debt 487 — Net assets acquired 432,660 224,345 Other, net 3,183 1,165 Aggregate purchase price $ 435,843 $ 225,510 The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the six months ended June 30, 2016 and 2015 (in years): Six Months Ended June 30, 2016 2015 Acquired intangible assets 9.5 15.5 Acquired intangible liabilities 8.8 47.0

Dispositions

Dispositions	6 Months Ended
	Jun. 30, 2016
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Dispositions	Dispositions During the three months ended June 30, 2016 , we completed a disposition of four senior care facilities for an aggregate gross sales price of $26.5 million , generating a gain of $4.2 million .

Intangible Assets and Liabiliti

Intangible Assets and Liabilities	6 Months Ended
	Jun. 30, 2016
Identified Intangibles, Net [Abstract]
Intangible Assets and Liabilities	Intangible Assets and Liabilities Intangible assets and liabilities consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization): June 30, 2016 December 31, 2015 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 282,494 10.3 $ 249,824 11.0 Tenant relationships 176,996 10.4 180,925 10.4 Above market leases 27,475 6.6 24,974 6.0 Below market leasehold interests 36,011 62.8 34,606 63.0 522,976 490,329 Accumulated amortization (236,864 ) (219,334 ) Total $ 286,112 16.2 $ 270,995 16.6 Liabilities: Below market leases $ 33,700 19.4 $ 22,240 27.2 Above market leasehold interests 11,632 53.4 11,582 53.7 45,332 33,822 Accumulated amortization (8,106 ) (7,211 ) Total $ 37,226 29.3 $ 26,611 38.0 The following is a summary of the net intangible amortization for the three and six months ended June 30, 2016 and 2015 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Amortization recorded against rental income related to above or (below) market leases $ (20 ) $ 444 $ 317 $ 919 Rental expense related to above or (below) market leasehold interests 107 128 203 233 Amortization expense related to in place leases and tenant relationships 13,450 12,149 24,217 24,105

Receivables and Other Assets

Receivables and Other Assets	6 Months Ended
	Jun. 30, 2016
Receivables and Other Assets [Abstract]
Receivables and Other Assets	Receivables and Other Assets Receivables and other assets consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands): June 30, 2016 December 31, 2015 Tenant receivables, net $ 6,310 $ 5,820 Other receivables, net 11,679 11,882 Deferred financing costs, net 4,861 5,524 Deferred leasing costs, net 18,920 17,923 Straight-line rent receivables, net 70,048 65,543 Prepaid expenses, deposits, equipment and other, net 34,033 34,584 Derivative financial instruments - interest rate swaps — 427 Total $ 145,851 $ 141,703 The following is a summary of the amortization of deferred leasing costs and financing costs for the three and six months ended June 30, 2016 and 2015 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Amortization expense related to deferred leasing costs $ 1,092 $ 942 $ 2,144 $ 1,928 Interest expense related to deferred financing costs (1) 332 338 663 665 (1) For the three and six months ended June 30, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.

Debt

Debt	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Debt	Debt Debt consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands): June 30, 2016 December 31, 2015 Unsecured revolving credit facility $ 261,000 $ 218,000 Unsecured term loans 455,000 455,000 Unsecured senior notes 600,000 600,000 Fixed rate mortgages 285,223 298,030 Variable rate mortgages 39,376 28,988 1,640,599 1,600,018 Deferred financing costs, net (7,495 ) (8,411 ) Discount, net (1,462 ) (911 ) Total $ 1,631,642 $ 1,590,696 Unsecured Credit Agreement Unsecured Revolving Credit Facility On February 11, 2015 , we executed an amendment to the unsecured revolving credit and term loan facility (the “Unsecured Credit Agreement”) which added an additional lender and increased the amount available under the unsecured revolving credit facility from $800.0 million to $850.0 million . The other existing terms of the Unsecured Credit Agreement were unchanged. The actual amount of credit available to us is a function of certain loan-to-value and debt service coverage ratios set forth in the unsecured revolving credit facility. The maximum principal amount of the unsecured revolving credit facility may be increased, subject to additional financing being provided by our existing lenders or new lenders being added to the unsecured revolving credit facility. The unsecured revolving credit facility matures on January 31, 2020 and is guaranteed by HTA. Borrowings under the unsecured revolving credit facility accrue interest at a rate equal to adjusted LIBOR , plus a margin ranging from 0.88% to 1.55% per annum based on our credit rating. We also pay a facility fee ranging from 0.13% to 0.30% per annum on the aggregate commitments under the unsecured revolving credit facility. As of June 30, 2016 , the margin associated with our borrowings was 1.05% per annum and the facility fee was 0.20% per annum. Unsecured Term Loan As of June 30, 2016 , we had a $300.0 million unsecured term loan outstanding that was guaranteed by HTA. Borrowings accrue interest at a rate equal to adjusted LIBOR , plus a margin ranging from 0.90% to 1.80% per annum based on our credit rating. The margin associated with our borrowings as of June 30, 2016 was 1.15% per annum. Including the impact of the interest rate swaps associated with our unsecured term loan, the interest rate was 1.77% per annum, based on our current credit rating. The unsecured term loan matures on January 31, 2019 , and includes a one -year extension exercisable at the option of the borrower, subject to certain conditions. $155.0 Million Unsecured Term Loan As of June 30, 2016 , HTALP had a $155.0 million unsecured term loan outstanding that is guaranteed by HTA. The loan matures on July 19, 2019 , and the interest rate thereon is equal to LIBOR, plus a margin ranging from 1.55% to 2.40% per annum based on our credit rating. The margin associated with our borrowings as of June 30, 2016 was 1.70% per annum. We have interest rate swaps in place that fix the interest rate at 2.99% per annum, based on our current credit rating. The maximum principal amount under this unsecured term loan may be increased by us, subject to such additional financing being provided by our existing lender. $300.0 Million Unsecured Senior Notes due 2021 As of June 30, 2016 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and that mature on July 15, 2021 . The unsecured senior notes are registered under the Securities Act of 1933, as amended (the “Securities Act”), bear interest at 3.38% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.21% of the principal amount thereof, with an effective yield to maturity of 3.50% per annum. $300.0 Million Unsecured Senior Notes due 2023 As of June 30, 2016 , HTALP had $300.0 million of unsecured senior notes outstanding that are guaranteed by HTA and that mature on April 15, 2023 . The unsecured senior notes are registered under the Securities Act, bear interest at 3.70% per annum and are payable semi-annually. The unsecured senior notes were offered at 99.19% of the principal amount thereof, with an effective yield to maturity of 3.80% per annum. Fixed and Variable Rate Mortgages As of June 30, 2016 , HTALP and its subsidiaries had fixed and variable rate mortgages with interest rates ranging from 1.95% to 6.49% per annum and a weighted average interest rate of 5.27% per annum. Including the impact of the interest rate swap associated with our variable rate mortgage, the weighted average interest rate was 5.58% per annum. Subsequent Events Subsequent to June 30, 2016 , through the date this Quarterly Report is filed with the SEC, we issued $350.0 million of senior unsecured 10 -year notes, with a coupon of 3.50% per annum due August 1, 2026 . We intend to use the net proceeds from the offering to repay a portion of the outstanding indebtedness under our revolving credit and term loan facility and for general corporate purposes, including, without limitation, working capital and investment in real estate. Future Debt Maturities The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of June 30, 2016 (in thousands): Year Amount 2016 $ 30,485 2017 117,409 2018 15,246 2019 465,135 2020 310,795 Thereafter 701,529 Total $ 1,640,599 The above scheduled debt maturities do not include the extension available to us under the Unsecured Credit Agreement as discussed above. Deferred Financing Costs As of June 30, 2016 , the future amortization of deferred financing costs is as follows (in thousands): Year Amount 2016 $ 893 2017 1,636 2018 1,543 2019 1,437 2020 889 Thereafter 1,097 Total $ 7,495 We are required by the terms of our applicable debt agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP ’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our debt agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered net operating income to unsecured interest expense. As of June 30, 2016 , we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our debt agreements include events of default provisions that we believe are customary for these types of facilities, including restricting HTA from making dividend distributions to its stockholders in the event HTA is in default thereunder, except to the extent necessary for HTA to maintain its REIT status.

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The following table lists the derivative financial instrument assets and (liabilities) held by us as of June 30, 2016 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 50,000 LIBOR 1.39 % $ (1,076 ) Swap 7/17/2019 105,000 LIBOR 1.24 (1,763 ) Swap 7/17/2019 25,685 LIBOR + 1.45% 4.98 (2,554 ) Swap 5/1/2020 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (142 ) Swap 6/15/2016 50,000 LIBOR 1.39 (71 ) Swap 7/17/2019 105,000 LIBOR 1.24 427 Swap 7/17/2019 26,092 LIBOR + 1.45% 4.98 (2,157 ) Swap 5/1/2020 As of June 30, 2016 and December 31, 2015 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location June 30, 2016 December 31, 2015 Balance Sheet Location June 30, 2016 December 31, 2015 Interest rate swaps Receivables and other assets $ — $ 427 Derivative financial instruments $ 5,393 $ 2,370 There were no derivatives offset in our accompanying condensed consolidated balance sheets as of June 30, 2016 and December 31, 2015 . As of June 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): June 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 5,393 — 5,393 2,370 (427 ) 1,943 We have agreements with each of our interest rate swap derivative counterparties which provide that if we default on certain of our unsecured indebtedness, our counterparties could declare us in default on our interest rate swap derivative obligations resulting in an acceleration of the indebtedness. In addition, we are exposed to credit risk in the event of non-performance by our derivative counterparties. We believe we mitigate the credit risk by entering into agreements with credit-worthy counterparties. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. As of June 30, 2016 , there have been no termination events or events of default related to our interest rate swaps.

Stockholders' Equity and Partne

Stockholders' Equity and Partners' Capital	6 Months Ended
	Jun. 30, 2016
Equity [Abstract]
Stockholders' Equity and Partners' Capital	Stockholders’ Equity and Partners’ Capital HTALP ’s partnership agreement provides that it will distribute cash flow from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one partnership unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of HTA’s common stock. In addition, for each share of common stock issued or redeemed by HTA, HTALP issues or redeems a corresponding number of partnership units. Common Stock Offerings During the second quarter of 2016 , HTA completed an underwritten public offering of 5,980,000 shares of common stock at a price of $28.75 per share. In January 2016, HTA entered into a new equity distribution agreement with respect to its at-the-market (“ATM”) offering program of common stock with an aggregate sales amount of up to $300.0 million . During the six months ended June 30, 2016 , HTA issued and sold 4,418,571 shares of its common stock, at an average price of $27.82 per share, and as of June 30, 2016 , $177.1 million remained available for issuance under the ATM. Common Unit Offerings During the second quarter of 2016 , HTA issued 2,620,512 partnership units in HTALP for approximately $70.8 million in connection with an acquisition transaction. Common Stock Dividends See our accompanying condensed consolidated statements of operations for the dividends declared during the three and six months ended June 30, 2016 and 2015 . On August 1, 2016 , HTA declared a quarterly cash dividend of $0.30 per share to be paid on October 7, 2016 to stockholders of record of its common stock on October 3, 2016 . Incentive Plan HTA’s Amended and Restated 2006 Incentive Plan (the “Plan”) permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. The Plan authorizes the granting of awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP ; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 5,000,000 . As of June 30, 2016 , there were 2,111,490 awards available for grant under the Plan. LTIP Units Awards under the LTIP consist of Series C units in HTALP and were subject to the achievement of certain performance and market conditions in order to vest. O nce vested, the Series C units were converted into common units of HTALP , which may be converted into shares of HTA’s common stock. The LTIP awards were fully expensed in 2013, except for 225,000 units that were forfeited in 2015. Restricted Common Stock For the three and six months ended June 30, 2016 , we recognized compensation expense of $1.2 million and $3.0 million , respectively. For the three and six months ended June 30, 2015 , we recognized compensation expense of $1.2 million and $3.1 million , respectively. Compensation expense for the three and six months ended June 30, 2016 and 2015 were recorded in general and administrative expenses in the accompanying condensed consolidated statements of operations. As of June 30, 2016 , there was $6.1 million of unrecognized compensation expense net of estimated forfeitures, which will be recognized over a remaining weighted average period of 1.7 years. The following is a summary of our restricted common stock activity during the six months ended June 30, 2016 and 2015 : June 30, 2016 June 30, 2015 Restricted Common Stock Weighted Average Grant Date Fair Value Restricted Common Stock Weighted Average Grant Date Fair Value Beginning balance 487,850 $ 23.13 463,050 $ 20.90 Granted 225,006 27.49 174,948 26.95 Vested (195,559 ) 22.84 (114,529 ) 21.89 Forfeited (22,167 ) 26.10 (19,898 ) 22.75 Ending Balance 495,130 $ 25.09 503,571 $ 22.63

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Financial Instruments Reported at Fair Value - Recurring The table below presents our assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 5,393 $ — $ 5,393 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 427 $ — $ 427 Liabilities: Derivative financial instruments $ — $ 2,370 $ — $ 2,370 Financial Instruments Reported at Fair Value - Non-Recurring As of June 30, 2016 , there were no assets measured at fair value on a non-recurring basis. The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: MOB (1) $ — $ 547 $ — $ 547 (1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement pertaining to this MOB. There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our interest rate swap derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our interest rate swap derivative positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our interest rate swap derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy. Financial Instruments Disclosed at Fair Value We consider the carrying values of cash and cash equivalents, tenant and other receivables, restricted cash and escrow deposits and accounts payable, and accrued liabilities, to approximate fair value for these financial instruments because of the short period of time between origination of the instruments and their expected realization. All of these financial instruments are considered Level 2. The fair value of debt is estimated using borrowing rates available to us with similar terms and maturities, which is considered a Level 2 input. As of June 30, 2016 , the fair value of the debt was $1,687.1 million compared to the carrying value of $1,631.6 million . As of December 31, 2015 , the fair value of the debt was $1,619.7 million compared to the carrying value of $1,590.7 million .

Per Share Data of HTA

Per Share Data of HTA	6 Months Ended
	Jun. 30, 2016
HTA, Inc.
Earnings Per Share
Per Share Data of HTA	Per Share Data of HTA HTA includes unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. For the three and six months ended June 30, 2016 and 2015 , all of HTA’s earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and six months ended June 30, 2016 and 2015 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator: Net income $ 13,516 $ 9,488 $ 23,552 $ 16,430 Net income attributable to noncontrolling interests (442 ) (196 ) (618 ) (334 ) Net income attributable to common stockholders $ 13,074 $ 9,292 $ 22,934 $ 16,096 Denominator: Weighted average shares outstanding - basic 136,528 125,194 132,932 125,184 Dilutive shares 3,984 1,930 2,944 1,930 Weighted average shares outstanding - diluted 140,512 127,124 135,876 127,114 Earnings per common share - basic Net income attributable to common stockholders $ 0.10 $ 0.07 $ 0.17 $ 0.13 Earnings per common share - diluted Net income attributable to common stockholders $ 0.09 $ 0.07 $ 0.17 $ 0.13

Per Unit Data of HTALP

Per Unit Data of HTALP	6 Months Ended
	Jun. 30, 2016
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Per Unit Data of HTALP	Per Unit Data of HTALP The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and six months ended June 30, 2016 and 2015 (in thousands, except per unit data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator: Net income $ 13,516 $ 9,488 $ 23,552 $ 16,430 Net loss (income) attributable to noncontrolling interests 4 (24 ) (27 ) (57 ) Net income attributable to common unitholders $ 13,520 $ 9,464 $ 23,525 $ 16,373 Denominator: Weighted average units outstanding - basic 140,512 127,203 135,877 127,266 Dilutive units — — — — Weighted average units outstanding - diluted 140,512 127,203 135,877 127,266 Earnings per common unit - basic: Net income attributable to common unitholders $ 0.10 $ 0.07 $ 0.17 $ 0.13 Earnings per common unit - diluted: Net income attributable to common unitholders $ 0.10 $ 0.07 $ 0.17 $ 0.13

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information The following is the supplemental cash flow information for the six months ended June 30, 2016 and 2015 (in thousands): Six Months Ended June 30, 2016 2015 Supplemental Disclosure of Cash Flow Information: Interest paid $ 26,749 $ 26,684 Income taxes paid 788 541 Supplemental Disclosure of Noncash Investing and Financing Activities: Accrued capital expenditures $ 2,961 $ 2,839 Note receivable included in the consideration of a disposition 3,000 — Debt assumed in connection with an acquisition 20,376 — Issuance of operating partnership units in connection with an acquisition 70,754 — Redeemable noncontrolling interest assumed in connection with an acquisition 5,231 — Dividend distributions declared, but not paid 41,770 36,307

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2016
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation Our accompanying condensed consolidated financial statements include our accounts and those of our subsidiaries and any consolidated variable interest entities (“VIEs”). All inter-company balances and transactions have been eliminated in the accompanying condensed consolidated financial statements.
Interim Unaudited Financial Data	Interim Unaudited Financial Data Our accompanying condensed consolidated financial statements have been prepared by us in accordance with GAAP in conjunction with the rules and regulations of the SEC. Certain information and footnote disclosures required for annual financial statements have been condensed or excluded pursuant to SEC rules and regulations. Accordingly, our accompanying condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. Our accompanying condensed consolidated financial statements reflect all adjustments, which are, in our opinion, of a normal recurring nature and necessary for a fair presentation of our financial position, results of operations and cash flows for the interim periods. Interim results of operations are not necessarily indicative of the results to be expected for the full year; such results may be less favorable for the full year. Our accompanying condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto included in our 2015 Annual Report on Form 10-K. There have been no significant changes to the Company’s significant accounting policies during the six months ended June 30, 2016 , except as noted below regarding the adoption of U.S. Financial Accounting Standards Board (the “FASB”) Accounting Standards Update (“ASU”) 2015-02, Amendments to the Consolidation Analysis and ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments.
Principles of Consolidation	Principles of Consolidation As of January 1, 2016, the Company adopted FASB ASU 2015-02, Amendments to the Consolidation Analysis, as described below in “Recently Issued or Adopted Accounting Pronouncements”, which simplifies consolidation accounting by reducing the number of consolidation models and changing various aspects of current GAAP, including certain consolidation criteria for VIEs. The consolidated financial statements include the accounts of HTA and its subsidiaries and consolidated joint venture arrangements. The portions of the operating partnership not owned by HTA are presented as non-controlling interests in HTA’s consolidated balance sheets and statements of operations, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by HTA are presented as redeemable non-controlling interests in HTA’s consolidated balance sheets. In addition, as described in Note 1 - Organization and Description of Business , certain third parties have been issued limited partner units in HTALP (“OP Units”). Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity in the consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of common shares issued and the carrying value of the OP Units converted is recorded as a component of equity. As of June 30, 2016 and December 31, 2015 , there were approximately 4.3 million and 1.9 million , respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. Our analysis of FASB ASU 2015-02 was concluded that the Company’s operating partnership and other joint venture arrangements are VIEs, as the limited partners in the related partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Accordingly, the Company consolidates its interest in the operating partnership and other joint venture arrangements. Although, as the Company holds what is deemed a majority voting interest in the operating partnership and other joint venture arrangements, it qualifies for the exemption from providing certain of the disclosure requirements associated with investments in VIEs. The Company will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
Investments in Real Estate	Investments in Real Estate Depreciation expense of buildings and improvements for the three months ended June 30, 2016 and 2015 was $29.9 million and $24.7 million , respectively. Depreciation expense of buildings and improvements for the six months ended June 30, 2016 and 2015 was $55.6 million and $48.0 million , respectively.
Recently Issued or Adopted Accounting Pronouncements	Recently Issued or Adopted Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 is a comprehensive new revenue recognition model requiring a company to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration (i.e., payment) to which the company expects to be entitled in exchange for those goods or services. In adopting ASU 2014-09, companies may use either a full retrospective or a modified retrospective approach. In July 2015, the FASB deferred the effective date of ASU 2014-09 to the first interim period within annual reporting periods beginning after December 15, 2017 along with the ability to early adopt as of the original effective date. We do not anticipate early adoption and we are evaluating the impact of adopting ASU 2014-09 on our consolidated financial statements. In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis. ASU 2015-02 affects reporting entities that are required to evaluate whether they should consolidate certain legal entities. The amendments in ASU 2015-02 affect the following areas: (i) limited partnerships and similar legal entities; (ii) evaluating fees paid to a decision maker or a service provider as a variable interest; (iii) the effect of fee arrangements on the primary beneficiary determination; (iv) the effect of related parties on the primary beneficiary determination; and (v) certain investment funds. ASU 2015-02 is effective for fiscal years and for interim periods within those fiscal years, beginning after December 15, 2015 with early adoption permitted. We adopted ASU 2015-02 as of January 1, 2016. The adoption had no material impact on our interests in joint venture arrangements. Accordingly, there was no material impact on previous or current reporting periods’ consolidated financial statements. In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs. ASU 2015-03 changes the presentation of debt issuance costs by requiring these costs related to a recognized debt liability to be presented in the consolidated balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. In August 2015, the FASB issued ASU 2015-15 to include the presentation and subsequent measurement of debt issuance costs associated with line-of-credit arrangements. ASU 2015-03 and 2015-15 are effective for the fiscal years beginning after December 15, 2015, and requires retrospective application with early adoption permitted. We adopted ASU 2015-03 and 2015-15 as of December 31, 2015. As a result of the adoption, all deferred financing costs, excluding costs related to the unsecured revolving credit facility, were reclassed to debt. Unsecured revolving credit facility costs remain classified as an asset on our consolidated balance sheets and will continue to be amortized over the remaining term. The guidance requires retrospective adoption for all prior periods presented. In September 2015, the FASB issued ASU 2015-16, Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments. ASU 2015-16 eliminates the requirement that an acquirer in a business combination has to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amount of the adjustment, including the effect on earnings of any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. ASU 2015-16 is effective for fiscal years beginning after December 15, 2015. We adopted ASU 2015-16 as of January 1, 2016. As a result of the adoption there was no impact in the previous or current reporting periods’ consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 will supersede the existing guidance for lease accounting and states that companies will be required to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. ASU 2016-02 requires qualitative and quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand the nature of the entity’s leasing activities, including significant judgments and changes in judgments. Within ASU 2016-02 lessor accounting remained fairly unchanged. In adopting ASU 2016-02, companies will be required to use a modified retrospective approach for leases that exist or are entered into after the beginning of the earliest comparative period in the financial statements. ASU 2016-02 is effective for the fiscal years beginning after December 15, 2018 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-02 on our consolidated financial statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Compensation Accounting. ASU 2016-09 includes multiple provisions intended to simplify various aspects of accounting for share-based compensation which includes, but is not limited to, the requirement that excess tax benefits be recorded within the income statement as opposed to additional paid-in-capital and treated as an operating activity within the statement of cash flows. In addition, ASU 2016-09 allows companies to make an accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016 with early adoption permitted. We do not anticipate early adoption, however, we are evaluating the impact of adopting ASU 2016-09 on our consolidated financial statements.

Investments in Real Estate (Tab

Investments in Real Estate (Tables)	6 Months Ended
	Jun. 30, 2016
Investments [Abstract]
Schedule of Purchase Price Allocation	The following investments were determined to be individually not significant, but significant on a collective basis. The actual revenues and earnings since the investment dates as well as the supplementary proforma information assuming these investments occurred as of the beginning of the prior periods, were not material to us. The purchase price allocation for each of our investments are preliminary and subject to change until allocations are finalized, which will be no later than 12 months from the date of acquisition. The preliminary allocations for these investments are set forth below in the aggregate for the six months ended June 30, 2016 and 2015 (in thousands): Six Months Ended June 30, 2016 2015 Land $ 53,806 $ 11,240 Building and improvements 347,729 200,071 Below market leasehold interests 1,404 2,350 Above market leases 3,582 3,279 In place leases 37,768 19,403 Below market leases (12,066 ) (5,912 ) Above market leasehold interests (50 ) (6,086 ) Below market debt 487 — Net assets acquired 432,660 224,345 Other, net 3,183 1,165 Aggregate purchase price $ 435,843 $ 225,510
Schedule of Weighted Average Lives of Acquired Intangible Assets and Liabilities	The acquired intangible assets and liabilities referenced above had weighted average lives of the following for the six months ended June 30, 2016 and 2015 (in years): Six Months Ended June 30, 2016 2015 Acquired intangible assets 9.5 15.5 Acquired intangible liabilities 8.8 47.0

Intangible Assets and Liabili23

Intangible Assets and Liabilities (Tables)	6 Months Ended
	Jun. 30, 2016
Identified Intangibles, Net [Abstract]
Schedule of Intangible Assets and Liabilities	Intangible assets and liabilities consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands, except weighted average remaining amortization): June 30, 2016 December 31, 2015 Balance Weighted Average Remaining Amortization in Years Balance Weighted Average Remaining Amortization in Years Assets: In place leases $ 282,494 10.3 $ 249,824 11.0 Tenant relationships 176,996 10.4 180,925 10.4 Above market leases 27,475 6.6 24,974 6.0 Below market leasehold interests 36,011 62.8 34,606 63.0 522,976 490,329 Accumulated amortization (236,864 ) (219,334 ) Total $ 286,112 16.2 $ 270,995 16.6 Liabilities: Below market leases $ 33,700 19.4 $ 22,240 27.2 Above market leasehold interests 11,632 53.4 11,582 53.7 45,332 33,822 Accumulated amortization (8,106 ) (7,211 ) Total $ 37,226 29.3 $ 26,611 38.0
Summary of Net Intangible Amortization	The following is a summary of the net intangible amortization for the three and six months ended June 30, 2016 and 2015 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Amortization recorded against rental income related to above or (below) market leases $ (20 ) $ 444 $ 317 $ 919 Rental expense related to above or (below) market leasehold interests 107 128 203 233 Amortization expense related to in place leases and tenant relationships 13,450 12,149 24,217 24,105

Receivables and Other Assets (T

Receivables and Other Assets (Tables)	6 Months Ended
	Jun. 30, 2016
Receivables and Other Assets [Abstract]
Schedule of Receivables and Other Assets	Receivables and other assets consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands): June 30, 2016 December 31, 2015 Tenant receivables, net $ 6,310 $ 5,820 Other receivables, net 11,679 11,882 Deferred financing costs, net 4,861 5,524 Deferred leasing costs, net 18,920 17,923 Straight-line rent receivables, net 70,048 65,543 Prepaid expenses, deposits, equipment and other, net 34,033 34,584 Derivative financial instruments - interest rate swaps — 427 Total $ 145,851 $ 141,703
Summary of Amortization of Deferred Leasing Costs and Deferred Financing Costs	The following is a summary of the amortization of deferred leasing costs and financing costs for the three and six months ended June 30, 2016 and 2015 (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Amortization expense related to deferred leasing costs $ 1,092 $ 942 $ 2,144 $ 1,928 Interest expense related to deferred financing costs (1) 332 338 663 665 (1) For the three and six months ended June 30, 2015, amounts have been adjusted to reflect the retrospective presentation of the early adoption of ASU 2015-03 and 2015-15 as of December 31, 2015.

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Schedule of Debt	Debt consisted of the following as of June 30, 2016 and December 31, 2015 (in thousands): June 30, 2016 December 31, 2015 Unsecured revolving credit facility $ 261,000 $ 218,000 Unsecured term loans 455,000 455,000 Unsecured senior notes 600,000 600,000 Fixed rate mortgages 285,223 298,030 Variable rate mortgages 39,376 28,988 1,640,599 1,600,018 Deferred financing costs, net (7,495 ) (8,411 ) Discount, net (1,462 ) (911 ) Total $ 1,631,642 $ 1,590,696
Summary of Debt Maturities and Scheduled Principal Debt Repayments	The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of June 30, 2016 (in thousands): Year Amount 2016 $ 30,485 2017 117,409 2018 15,246 2019 465,135 2020 310,795 Thereafter 701,529 Total $ 1,640,599
Schedule of Amortization of Deferred Financing Costs	As of June 30, 2016 , the future amortization of deferred financing costs is as follows (in thousands): Year Amount 2016 $ 893 2017 1,636 2018 1,543 2019 1,437 2020 889 Thereafter 1,097 Total $ 7,495

Derivative Financial Instrume26

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instrument Assets and (Liabilities) Held	The following table lists the derivative financial instrument assets and (liabilities) held by us as of June 30, 2016 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 50,000 LIBOR 1.39 % $ (1,076 ) Swap 7/17/2019 105,000 LIBOR 1.24 (1,763 ) Swap 7/17/2019 25,685 LIBOR + 1.45% 4.98 (2,554 ) Swap 5/1/2020 The following table lists the derivative financial instrument assets and (liabilities) held by us as of December 31, 2015 (in thousands): Notional Amount Index Rate Fair Value Instrument Maturity $ 100,000 LIBOR 0.86 % $ (142 ) Swap 6/15/2016 50,000 LIBOR 1.39 (71 ) Swap 7/17/2019 105,000 LIBOR 1.24 427 Swap 7/17/2019 26,092 LIBOR + 1.45% 4.98 (2,157 ) Swap 5/1/2020
Gross Fair Value of Derivative Financial Instruments	As of June 30, 2016 and December 31, 2015 , the gross fair value of our derivative financial instruments was as follows (in thousands): Asset Derivatives Liability Derivatives Fair Value Fair Value Derivatives Not Designated as Hedging Instruments: Balance Sheet Location June 30, 2016 December 31, 2015 Balance Sheet Location June 30, 2016 December 31, 2015 Interest rate swaps Receivables and other assets $ — $ 427 Derivative financial instruments $ 5,393 $ 2,370
Schedule of Derivative Liabilities Subject to Master Netting Arrangements	As of June 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): June 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 5,393 — 5,393 2,370 (427 ) 1,943
Schedule of Derivative Assets Subject to Master Netting Arrangements	As of June 30, 2016 and December 31, 2015 , we had derivatives subject to enforceable master netting arrangements which allowed for net cash settlement with the respective counterparties (in thousands): June 30, 2016 December 31, 2015 Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Gross Amounts Amounts Subject to Enforceable Master Netting Arrangements Net Amounts Asset derivatives $ — $ — $ — $ 427 $ (427 ) $ — Liability derivatives 5,393 — 5,393 2,370 (427 ) 1,943

Stockholders' Equity and Part27

Stockholders' Equity and Partners' Capital (Tables)	6 Months Ended
	Jun. 30, 2016
Equity [Abstract]
Schedule of Restricted Common Stock Activity	The following is a summary of our restricted common stock activity during the six months ended June 30, 2016 and 2015 : June 30, 2016 June 30, 2015 Restricted Common Stock Weighted Average Grant Date Fair Value Restricted Common Stock Weighted Average Grant Date Fair Value Beginning balance 487,850 $ 23.13 463,050 $ 20.90 Granted 225,006 27.49 174,948 26.95 Vested (195,559 ) 22.84 (114,529 ) 21.89 Forfeited (22,167 ) 26.10 (19,898 ) 22.75 Ending Balance 495,130 $ 25.09 503,571 $ 22.63

Fair Value of Financial Instr28

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The table below presents our assets and liabilities measured at fair value on a recurring basis as of June 30, 2016 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ — $ — $ — Liabilities: Derivative financial instruments $ — $ 5,393 $ — $ 5,393 The table below presents our assets and liabilities measured at fair value on a recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: Derivative financial instruments $ — $ 427 $ — $ 427 Liabilities: Derivative financial instruments $ — $ 2,370 $ — $ 2,370
Schedule of Fair Value, Assets Measured on Non-Recurring Basis	The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2015 , aggregated by the applicable level in the fair value hierarchy (in thousands): Level 1 Level 2 Level 3 Total Assets: MOB (1) $ — $ 547 $ — $ 547 (1) During the year ended December 31, 2015, we recognized a $0.9 million impairment charge to the carrying value of an MOB. The estimated fair value as of December 31, 2015 was based upon a pending sales agreement pertaining to this MOB.

Per Share Data of HTA (Tables)

Per Share Data of HTA (Tables)	6 Months Ended
	Jun. 30, 2016
HTA, Inc.
Earnings Per Share
Schedule of Earnings Per Share, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the three and six months ended June 30, 2016 and 2015 (in thousands, except per share data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator: Net income $ 13,516 $ 9,488 $ 23,552 $ 16,430 Net income attributable to noncontrolling interests (442 ) (196 ) (618 ) (334 ) Net income attributable to common stockholders $ 13,074 $ 9,292 $ 22,934 $ 16,096 Denominator: Weighted average shares outstanding - basic 136,528 125,194 132,932 125,184 Dilutive shares 3,984 1,930 2,944 1,930 Weighted average shares outstanding - diluted 140,512 127,124 135,876 127,114 Earnings per common share - basic Net income attributable to common stockholders $ 0.10 $ 0.07 $ 0.17 $ 0.13 Earnings per common share - diluted Net income attributable to common stockholders $ 0.09 $ 0.07 $ 0.17 $ 0.13

Per Unit Data of HTALP (Tables)

Per Unit Data of HTALP (Tables)	6 Months Ended
	Jun. 30, 2016
Healthcare Trust of America Holdings, LP (HTALP)
Earnings Per Share
Schedule of Earnings Per Unit, Basic and Diluted	The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the three and six months ended June 30, 2016 and 2015 (in thousands, except per unit data): Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Numerator: Net income $ 13,516 $ 9,488 $ 23,552 $ 16,430 Net loss (income) attributable to noncontrolling interests 4 (24 ) (27 ) (57 ) Net income attributable to common unitholders $ 13,520 $ 9,464 $ 23,525 $ 16,373 Denominator: Weighted average units outstanding - basic 140,512 127,203 135,877 127,266 Dilutive units — — — — Weighted average units outstanding - diluted 140,512 127,203 135,877 127,266 Earnings per common unit - basic: Net income attributable to common unitholders $ 0.10 $ 0.07 $ 0.17 $ 0.13 Earnings per common unit - diluted: Net income attributable to common unitholders $ 0.10 $ 0.07 $ 0.17 $ 0.13

Supplemental Cash Flow Inform31

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following is the supplemental cash flow information for the six months ended June 30, 2016 and 2015 (in thousands): Six Months Ended June 30, 2016 2015 Supplemental Disclosure of Cash Flow Information: Interest paid $ 26,749 $ 26,684 Income taxes paid 788 541 Supplemental Disclosure of Noncash Investing and Financing Activities: Accrued capital expenditures $ 2,961 $ 2,839 Note receivable included in the consideration of a disposition 3,000 — Debt assumed in connection with an acquisition 20,376 — Issuance of operating partnership units in connection with an acquisition 70,754 — Redeemable noncontrolling interest assumed in connection with an acquisition 5,231 — Dividend distributions declared, but not paid 41,770 36,307

Organization and Description 32

Organization and Description of Business (Details) $ in Billions	6 Months Ended
	Jun. 30, 2016USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General partnership interest percentage	96.90%
Purchased property inception to current date	$ 4

Summary of Significant Accoun33

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Building Improvements
Partners' Capital Notes [Abstract]
Depreciation expense	$ 29.9	$ 24.7	$ 55.6	$ 48
Healthcare Trust of America Holdings, LP (HTALP)
Partners' Capital Notes [Abstract]
Limited partner's capital, units outstanding	4,343,197		4,343,197		1,929,942
Limited partner's capital, units issued	4,343,197		4,343,197		1,929,942
Healthcare Trust of America Holdings, LP (HTALP) | Noncontrolling Interests
Partners' Capital Notes [Abstract]
Limited partner's capital, units outstanding	4,300,000		4,300,000		1,900,000
Limited partner's capital, units issued	4,300,000		4,300,000		1,900,000

Investments in Real Estate - Ac

Investments in Real Estate - Acquisitions (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Investments [Abstract]
Closing costs	$ 2,100
Mortgage loans assumed	19,900
Business Acquisition [Line Items]
Land	53,806	$ 11,240
Building and improvements	347,729	200,071
Below market leasehold interests	1,404	2,350
Above market leases	3,582	3,279
In place leases	37,768	19,403
Below market leases	(12,066)	(5,912)
Above market leasehold interests	(50)	(6,086)
Below market debt	487	0
Net assets acquired	432,660	224,345
Other, net	3,183	1,165
Aggregate purchase price	$ 435,843	$ 225,510
Partnership Units
Business Acquisition [Line Items]
Number of operating partnership units issued in acquisition (shares)	2,620,512
Market value of operating partnership units issued in acquisition	$ 70,800

Investments in Real Estate - We

Investments in Real Estate - Weighted Average Lives (Details)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Investments [Abstract]
Acquired intangible assets	9 years 6 months	15 years 6 months
Acquired intangible liabilities	8 years 9 months 18 days	47 years

Dispositions (Details)

Dispositions (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016USD ($)facility	Jun. 30, 2015USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2015USD ($)
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract]
Number of senior care facilities disposed | facility	4
Aggregate gross sales price of facilities disposed	$ 26,500
Gain from sale of dispositions of properties	$ 4,212	$ 0	$ 4,212	$ 0

Intangible Assets and Liabili37

Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Assets:
Gross	$ 522,976	$ 490,329
Accumulated amortization	(236,864)	(219,334)
Total	$ 286,112	$ 270,995
Weighted Average Remaining Amortization in Years	16 years 2 months 12 days	16 years 7 months 6 days
Liabilities:
Gross	$ 45,332	$ 33,822
Accumulated amortization	(8,106)	(7,211)
Total	$ 37,226	$ 26,611
Weighted Average Remaining Amortization in Years	29 years 3 months 18 days	38 years
Below market leases
Liabilities:
Gross	$ 33,700	$ 22,240
Weighted Average Remaining Amortization in Years	19 years 4 months 24 days	27 years 2 months 12 days
Above market leasehold interests
Liabilities:
Gross	$ 11,632	$ 11,582
Weighted Average Remaining Amortization in Years	53 years 4 months 24 days	53 years 8 months 12 days
In place leases
Assets:
Gross	$ 282,494	$ 249,824
Weighted Average Remaining Amortization in Years	10 years 3 months 18 days	11 years
Tenant relationships
Assets:
Gross	$ 176,996	$ 180,925
Weighted Average Remaining Amortization in Years	10 years 4 months 24 days	10 years 4 months 24 days
Above market leases
Assets:
Gross	$ 27,475	$ 24,974
Weighted Average Remaining Amortization in Years	6 years 7 months 6 days	6 years
Below market leasehold interests
Assets:
Gross	$ 36,011	$ 34,606
Weighted Average Remaining Amortization in Years	62 years 9 months 18 days	63 years

Intangible Assets and Liabili38

Intangible Assets and Liabilities - Summary of Intangible Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Amortization recorded against rental income related to above or (below) market leases
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ (20)	$ 444	$ 317	$ 919
Rental expense related to above or (below) market leasehold interests
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	107	128	203	233
Amortization expense related to in place leases and tenant relationships
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items]
Amortization of intangible assets and liabilities	$ 13,450	$ 12,149	$ 24,217	$ 24,105

Receivables and Other Assets -

Receivables and Other Assets - Schedule of Receivables and Other Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Receivables and Other Assets [Abstract]
Tenant receivables, net	$ 6,310	$ 5,820
Other receivables, net	11,679	11,882
Deferred financing costs, net	4,861	5,524
Deferred leasing costs, net	18,920	17,923
Straight-line rent receivables, net	70,048	65,543
Prepaid expenses, deposits, equipment and other, net	34,033	34,584
Derivative financial instruments, asset	0	427
Total	$ 145,851	$ 141,703

Receivables and Other Assets 40

Receivables and Other Assets - Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Receivables and Other Assets [Abstract]
Amortization expense related to deferred leasing costs	$ 1,092	$ 942	$ 2,144	$ 1,928
Interest expense related to deferred financing costs	$ 332	$ 338	$ 663	$ 665

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Debt Instrument
Total debt, gross	$ 1,640,599	$ 1,600,018
Deferred financing costs, net	(7,495)	(8,411)
Discount, net	(1,462)	(911)
Total	1,631,642	1,590,696
Unsecured term loans
Debt Instrument
Total debt, gross	455,000	455,000
Unsecured senior notes
Debt Instrument
Total debt, gross	600,000	600,000
Mortgages | Fixed rate mortgages
Debt Instrument
Total debt, gross	285,223	298,030
Mortgages | Variable rate mortgages
Debt Instrument
Total debt, gross	39,376	28,988
Unsecured revolving credit facility
Debt Instrument
Line of credit facility, amount outstanding	$ 261,000	$ 218,000

Debt - Textuals (Details)

Debt - Textuals (Details) - USD ($)	1 Months Ended	6 Months Ended
	Aug. 02, 2016	Jun. 30, 2016	Dec. 31, 2015	Feb. 11, 2015	Dec. 31, 2014
Debt Instrument
Outstanding amount		$ 1,640,599,000	$ 1,600,018,000
Unsecured term loans
Debt Instrument
Outstanding amount		$ 455,000,000	455,000,000
Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		1.15%
Outstanding amount		$ 300,000,000
Unsecured credit agreement, extension option period		1 year
Weighted average interest rate with interest rate swap impact		1.77%
Unsecured term loans | $155.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		1.70%
Debt instrument, face amount		$ 155,000,000
Weighted average interest rate with interest rate swap impact		2.99%
Unsecured senior notes
Debt Instrument
Outstanding amount		$ 600,000,000	$ 600,000,000
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2021
Debt Instrument
Debt instrument, face amount		$ 300,000,000
Debt instrument, stated interest rate		3.38%
Debt instrument, percentage of principal amount received		99.21%
Debt instrument, effective interest rate		3.50%
Unsecured senior notes | $300.0 Million Unsecured Senior Notes due 2023
Debt Instrument
Debt instrument, face amount		$ 300,000,000
Debt instrument, stated interest rate		3.70%
Debt instrument, percentage of principal amount received		99.19%
Debt instrument, effective interest rate		3.80%
Unsecured senior notes | $350.0 Million Senior Unsecured Notes due 2026 | Subsequent Event
Debt Instrument
Debt instrument, face amount	$ 350,000,000
Debt instrument, stated interest rate	3.50%
Debt term	10 years
Mortgages
Debt Instrument
Weighted average interest rate with interest rate swap impact		5.58%
Weighted average interest rate		5.27%
Minimum | Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		0.90%
Minimum | Unsecured term loans | $155.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		1.55%
Minimum | Mortgages
Debt Instrument
Debt instrument, effective interest rate		1.95%
Maximum | Unsecured term loans | $300.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		1.80%
Maximum | Unsecured term loans | $155.0 Million Unsecured Term Loan
Debt Instrument
Basis spread on variable rate		2.40%
Maximum | Mortgages
Debt Instrument
Debt instrument, effective interest rate		6.49%
Unsecured revolving credit facility
Debt Instrument
Line of credit facility, borrowing capacity				$ 850,000,000	$ 800,000,000
Basis spread on variable rate		1.05%
Line of credit facility, commitment fee percentage		0.20%
Unsecured revolving credit facility | Minimum
Debt Instrument
Basis spread on variable rate		0.875%
Line of credit facility, commitment fee percentage		0.125%
Unsecured revolving credit facility | Maximum
Debt Instrument
Basis spread on variable rate		1.55%
Line of credit facility, commitment fee percentage		0.30%

Debt - Principal Maturity Sched

Debt - Principal Maturity Schedule (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Debt Disclosure [Abstract]
2,016	$ 30,485
2,017	117,409
2,018	15,246
2,019	465,135
2,020	310,795
Thereafter	701,529
Total	$ 1,640,599	$ 1,600,018

Debt - Amortization of Deferred

Debt - Amortization of Deferred Financing Costs (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Debt Disclosure [Abstract]
2,016	$ 893
2,017	1,636
2,018	1,543
2,019	1,437
2,020	889
Thereafter	1,097
Total	$ 7,495	$ 8,411

Derivative Financial Instrume45

Derivative Financial Instruments - Table of Derivative Financial Instruments (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015
Derivative
Fair Value, Liability	$ (5,393)	$ (2,370)
Fair Value, Asset	0	427
Swap at 0.86%
Derivative
Notional Amount		$ 100,000
Index		LIBOR
Rate		0.86%
Fair Value, Liability		$ (142)
Swap at 1.39%
Derivative
Notional Amount	$ 50,000	$ 50,000
Index	LIBOR	LIBOR
Rate	1.39%	1.39%
Fair Value, Liability	$ (1,076)	$ (71)
Swap at 1.24%
Derivative
Notional Amount	$ 105,000	$ 105,000
Index	LIBOR	LIBOR
Rate	1.24%	1.24%
Fair Value, Liability	$ (1,763)
Fair Value, Asset		$ 427
Swap at 4.98%
Derivative
Notional Amount	$ 25,685	$ 26,092
Index	LIBOR + 1.45%	LIBOR + 1.45%
Rate	4.98%	4.98%
Fair Value, Liability	$ (2,554)	$ (2,157)
Basis spread on variable rate	1.45%	1.45%

Derivative Financial Instrume46

Derivative Financial Instruments - Derivative Instruments Fair Value Table (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Derivatives, Fair Value
Derivative financial instruments, asset	$ 0	$ 427
Derivative financial instruments, liability	5,393	2,370
Not Designated as Hedging Instrument | Interest rate swaps | Receivables and other assets
Derivatives, Fair Value
Derivative financial instruments, asset	0	427
Not Designated as Hedging Instrument | Interest rate swaps | Derivative financial instruments
Derivatives, Fair Value
Derivative financial instruments, liability	$ 5,393	$ 2,370

Derivative Financial Instrume47

Derivative Financial Instruments - Derivative Offsetting (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Asset derivatives
Gross Amounts	$ 0	$ 427
Amounts Subject to Enforceable Master Netting Arrangements	0	(427)
Net Amounts	0	0
Liability derivatives
Gross Amounts	5,393	2,370
Amounts Subject to Enforceable Master Netting Arrangements	0	(427)
Net Amounts	$ 5,393	$ 1,943

Stockholders' Equity and Part48

Stockholders' Equity and Partners' Capital - Textuals (Details)	Aug. 01, 2016$ / shares	Jan. 31, 2016USD ($)	Jun. 30, 2016USD ($)$ / sharesshares	Jun. 30, 2015USD ($)$ / shares	Jun. 30, 2016USD ($)$ / sharesshares	Jun. 30, 2015USD ($)$ / sharesshares	Dec. 31, 2015shares
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares			$ 0.295	$ 0.290	$ 0.590	$ 0.580
LTIP Units
Incentive Plan
Number of forfeited units/shares							225,000
Restricted Common Stock
Incentive Plan
Number of forfeited units/shares					22,167	19,898
Nonvested awards, total compensation cost not yet recognized | $			$ 6,100,000		$ 6,100,000
Period for recognition					1 year 8 months 12 days
Restricted Common Stock | General and Administrative Expense
Incentive Plan
Compensation expense | $			$ 1,200,000	$ 1,200,000	$ 3,000,000	$ 3,100,000
2006 Incentive Plan
Incentive Plan
Number of shares authorized			5,000,000		5,000,000
Number of shares available for grant			2,111,490		2,111,490
Subsequent Event
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares	$ 0.3000
Public Offering
Common Stock Offerings
Number of shares issued			5,980,000
Share price (in usd per share) | $ / shares			$ 28.75		$ 28.75
ATM
Common Stock Offerings
Number of shares issued					4,418,571
Share price (in usd per share) | $ / shares			$ 27.82		$ 27.82
Remaining amount of shares available for issuance | $					$ 177,100,000
ATM | Maximum
Common Stock Offerings
Maximum amount of common stock authorized | $		$ 300,000,000
Healthcare Trust of America Holdings, LP (HTALP)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend distribution ratio					1
Common Unit Offerings
Number of partnership units issued in connection with an acquisition			2,620,512
Issuance of partnership units in connection with an acquisition | $			$ 70,800,000		$ 70,754,000
Common Stock Dividends
Dividends declared (in usd per share) | $ / shares			$ 0.295	$ 0.290	$ 0.590	$ 0.580

Stockholders' Equity and Part49

Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details) - Restricted Common Stock - $ / shares	6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Restricted Common Stock
Balance as of beginning of period (shares)	487,850	463,050	463,050
Granted (shares)	225,006	174,948
Vested (shares)	(195,559)	(114,529)
Forfeited (shares)	(22,167)	(19,898)
Balance as of end of period (shares)	495,130	503,571	487,850
Weighted Average Grant Date Fair Value
Balance as of beginning of period (usd per share)	$ 23.13	$ 20.90	$ 20.90
Granted (usd per share)	27.49	26.95
Vested (usd per share)	22.84	21.89
Forfeited (usd per share)	26.10	22.75
Balance as of end of period (usd per share)	$ 25.09	$ 22.63	$ 23.13

Fair Value of Financial Instr50

Fair Value of Financial Instruments - Assets and Liabilities at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Assets:
Derivative financial instruments, asset	$ 0	$ 427
Liabilities:
Derivative financial instruments, liability	5,393	2,370
Fair Value, Measurements, Recurring
Assets:
Derivative financial instruments, asset	0	427
Liabilities:
Derivative financial instruments, liability	5,393	2,370
Fair Value, Measurements, Recurring | Level 1
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instruments, liability	0	0
Fair Value, Measurements, Recurring | Level 2
Assets:
Derivative financial instruments, asset	0	427
Liabilities:
Derivative financial instruments, liability	5,393	2,370
Fair Value, Measurements, Recurring | Level 3
Assets:
Derivative financial instruments, asset	0	0
Liabilities:
Derivative financial instruments, liability	$ 0	$ 0

Fair Value of Financial Instr51

Fair Value of Financial Instruments - Assets on Nonrecurring Basis (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2016
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	$ 547,000	$ 0
Impairment on property being marketed for sale	900,000
Level 1
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	0
Level 2
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	547,000
Level 3
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Line Items]
Assets: MOB	$ 0

Fair Value of Financial Instr52

Fair Value of Financial Instruments - Textuals (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Fair Value Disclosures [Abstract]
Debt, fair value	$ 1,687,100	$ 1,619,700
Debt, carrying value	$ 1,631,642	$ 1,590,696

Per Share Data of HTA (Details)

Per Share Data of HTA (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Numerator:
Net income		$ 13,516	$ 9,488	$ 23,552	$ 16,430
Net income attributable to noncontrolling interests	[1]	(442)	(196)	(618)	(334)
Net income attributable to common stockholders/unitholders		$ 13,074	$ 9,292	$ 22,934	$ 16,096
Denominator:
Weighted average shares outstanding - basic		136,528	125,194	132,932	125,184
Weighted average number of shares/units outstanding — diluted		140,512	127,124	135,876	127,114
Earnings per common share - basic
Net income attributable to common stockholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common share - diluted
Net income attributable to common stockholders (in usd per share)		$ 0.09	$ 0.07	$ 0.17	$ 0.13
HTA, Inc.
Numerator:
Net income		$ 13,516	$ 9,488	$ 23,552	$ 16,430
Net income attributable to noncontrolling interests		(442)	(196)	(618)	(334)
Net income attributable to common stockholders/unitholders		$ 13,074	$ 9,292	$ 22,934	$ 16,096
Denominator:
Weighted average shares outstanding - basic		136,528	125,194	132,932	125,184
Dilutive shares		3,984	1,930	2,944	1,930
Weighted average number of shares/units outstanding — diluted		140,512	127,124	135,876	127,114
Earnings per common share - basic
Net income attributable to common stockholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common share - diluted
Net income attributable to common stockholders (in usd per share)		$ 0.09	$ 0.07	$ 0.17	$ 0.13
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Per Unit Data of HTALP (Details

Per Unit Data of HTALP (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Numerator:
Net income		$ 13,516	$ 9,488	$ 23,552	$ 16,430
Net loss (income) attributable to noncontrolling interests	[1]	(442)	(196)	(618)	(334)
Net income attributable to common stockholders/unitholders		$ 13,074	$ 9,292	$ 22,934	$ 16,096
Denominator:
Weighted average units outstanding - basic		136,528	125,194	132,932	125,184
Weighted average number of shares/units outstanding — diluted		140,512	127,124	135,876	127,114
Earnings per common unit - basic:
Net income attributable to common unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common unit - diluted:
Net income attributable to common unitholders (in usd per share)		$ 0.09	$ 0.07	$ 0.17	$ 0.13
Healthcare Trust of America Holdings, LP (HTALP)
Numerator:
Net income		$ 13,516	$ 9,488	$ 23,552	$ 16,430
Net loss (income) attributable to noncontrolling interests		4	(24)	(27)	(57)
Net income attributable to common stockholders/unitholders		$ 13,520	$ 9,464	$ 23,525	$ 16,373
Denominator:
Weighted average units outstanding - basic		140,512	127,203	135,877	127,266
Dilutive units		0	0	0	0
Weighted average number of shares/units outstanding — diluted		140,512	127,203	135,877	127,266
Earnings per common unit - basic:
Net income attributable to common unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
Earnings per common unit - diluted:
Net income attributable to common unitholders (in usd per share)		$ 0.10	$ 0.07	$ 0.17	$ 0.13
[1]	Includes amounts attributable to redeemable noncontrolling interests.

Supplemental Cash Flow Inform55

Supplemental Cash Flow Information (Details) - USD ($) shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Supplemental Disclosure of Cash Flow Information:
Interest paid	$ 26,749	$ 26,684
Income taxes paid	788	541
Supplemental Disclosure of Noncash Investing and Financing Activities:
Accrued capital expenditures	2,961	2,839
Note receivable included in the consideration of a disposition	3,000	0
Debt assumed in connection with an acquisition	$ 20,376	$ 0
Issuance of operating partnership units in connection with an acquisition	70,754	0
Redeemable noncontrolling interest assumed in connection with an acquisition	$ 5,231	$ 0
Dividend distributions declared, but not paid	$ 41,770	$ 36,307